These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21324557)

  • 1. [Management of antiretroviral drug toxicity].
    Domingo P; Lozano F
    Enferm Infecc Microbiol Clin; 2011; 29(7):535-44. PubMed ID: 21324557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of etravirine in combination antiretroviral therapy].
    Domingo P
    Enferm Infecc Microbiol Clin; 2009 Dec; 27 Suppl 2():46-51. PubMed ID: 20116628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
    Leonard EG; McComsey GA
    Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The side effects of antiretroviral therapy].
    Hartmann M
    Hautarzt; 2006 Nov; 57(11):969-74. PubMed ID: 17036249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver toxicity of antiretroviral drugs.
    Jones M; Núñez M
    Semin Liver Dis; 2012 May; 32(2):167-76. PubMed ID: 22760656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety and tolerability of etravirine].
    Portilla J
    Enferm Infecc Microbiol Clin; 2009 Dec; 27 Suppl 2():21-6. PubMed ID: 20116624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving toxicities associated with anti-HIV therapies.
    Bean P
    Am Clin Lab; 2002 May; 21(4):12-5. PubMed ID: 12087632
    [No Abstract]   [Full Text] [Related]  

  • 9. Sweetening the toxic cocktail. Managing the side effects of HIV medications.
    Doerfler RE
    Adv Nurse Pract; 2002 May; 10(5):52-4, 57-8, 103. PubMed ID: 12420531
    [No Abstract]   [Full Text] [Related]  

  • 10. Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.
    Cicconi P; Cozzi-Lepri A; Castagna A; Trecarichi EM; Antinori A; Gatti F; Cassola G; Sighinolfi L; Castelli P; d'Arminio Monforte A;
    HIV Med; 2010 Feb; 11(2):104-13. PubMed ID: 19732176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Side effects of antiretroviral therapy].
    Teodor A; Teodor D; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):23-6. PubMed ID: 15688751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etravirine in first-line therapy].
    Garcés PA; Tena EV
    Enferm Infecc Microbiol Clin; 2009 Dec; 27 Suppl 2():12-20. PubMed ID: 20116623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of first antiretroviral regimen in HIV/hepatitis C virus co-infection.
    Cooper CL; Breau C; Laroche A; Lee C; Garber G
    HIV Med; 2006 Jan; 7(1):32-7. PubMed ID: 16313290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV disease and advanced age: an increasing therapeutic challenge.
    Manfredi R
    Drugs Aging; 2002; 19(9):647-69. PubMed ID: 12381235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly active antiretroviral therapy-induced liver injury.
    Inductivo-Yu I; Bonacini M
    Curr Drug Saf; 2008 Jan; 3(1):4-13. PubMed ID: 18690975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected metabolic and morphologic complications associated with highly active antiretroviral therapy.
    Smith KY
    J Infect Dis; 2002 May; 185 Suppl 2():S123-7. PubMed ID: 12001033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common adverse effects of antiretroviral therapy for HIV disease.
    Reust CE
    Am Fam Physician; 2011 Jun; 83(12):1443-51. PubMed ID: 21671545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potential role of rilpivirine in simplification regimens].
    Casado JL; Moreno S
    Enferm Infecc Microbiol Clin; 2013 Jun; 31 Suppl 2():30-5. PubMed ID: 24252531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety profile of rilpivirine: general and neuropsychiatric tolerability, safety in patients with hepatitis B or C viruses, and lipid profile].
    López Cortés LF; Martínez E; von Wichmann MÁ
    Enferm Infecc Microbiol Clin; 2013 Jun; 31 Suppl 2():6-11. PubMed ID: 24252528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of adverse events associated with antiretroviral therapy and the relationship to treatment adherence.
    Lenzi L; Wiens A; Pontarolo R
    Int J Clin Pharmacol Ther; 2013 Feb; 51(2):141-6. PubMed ID: 23253950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.